My bookmarksSign up free
Source

Commission Implementing Regulation (EU) 2025/1257 of 26 June 2025 approving 2-methyl-2H-isothiazol-3-one (MIT) as an existing active substance for use in biocidal products of product-type 6 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council

Commission Implementing Regulation (EU) 2025/1257 of 26 June 2025 approving 2-methyl-2H-isothiazol-3-one (MIT) as an existing active substance for use in biocidal products of product-type 6 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council

Implementing Regulation (EU) 2025/1257 · Regulation · 3 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Open ↗

2-methyl-2H-isothiazol-3-one (MIT) is approved as an active substance for use in biocidal products of product-type 6, subject to the conditions set out in the Annex.

Article 2

Open ↗

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .

Supplementary provisions

ANNEXSupplementary provisions

Open ↗

ANNEX Common Name IUPAC Name Identification Numbers Minimum degree of purity of the active substance  ( 1 ) Date of approval Expiry date of approval Product type Specific conditions MIT IUPAC name: 2-methyl-2H-isothiazol-3-one EC No: 220-239-6 CAS No: 2682-20-4 > 950 g/kg 1 February 2027 31 January 2037 6 (1) The authorisation of biocidal products containing 2-methyl-2H-isothiazol-3-one (MIT) as an active substance is subject to the following conditions: (a) the product assessment pays particular attention to the exposures, the risks and the efficacy linked to any uses covered by an application for authorisation, but not addressed in the Union level assessment of the active substance; (b) the product assessment pays particular attention to: (i) industrial and professional users; (ii) non-professional users: by exposure to the active substance via treated articles; (iii) soil compartment; (c) Member States’ competent authorities or, in the case of a Union authorisation the Commission, specify in the summary of the biocidal product characteristics the relevant instructions for use and precautions to be indicated on the label of the treated articles under Article 58(3), second subparagraph, point (e), of Regulation (EU) No 528/2012. (2) The placing on the market of treated articles is subject to the following conditions: (a) the person responsible for the placing on the market of a treated article treated with or incorporating MIT ensures that the label of that treated article provides the information listed in Article 58(3), second subparagraph, of Regulation (EU) No 528/2012; (b) mixtures (other than paints) treated with or incorporating MIT and placed on the market for use by non-professional users do not contain MIT at a concentration triggering classification of the mixture as skin sensitiser category 1 in accordance with Regulation (EC) No 1272/2008 of the European Parliament and of the Council  ( 2 ) , unless exposure can be avoided by other means than the wearing of personal protective equipment; (c) the person responsible for the placing on the market for use by non-professionals of a paint treated with or incorporating MIT at a concentration triggering classification of the mixture as skin sensitiser category 1 in accordance with Regulation (EC) No 1272/2008 ensures that: (i) the paint is supplied with appropriate protective gloves in compliance with European Standard EN 374 or equivalent; (ii) the label indicates that protective gloves must be worn during use. ( 1 )   The purity indicated in this column was the minimum degree of purity of the active substance evaluated. The active substance in the product placed on the market may be of equal or different purity if it has been proven to be technically equivalent to the evaluated active substance. ( 2 )   Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, amending and repealing Directives 67/548/EEC and 1999/45/EC, and amending Regulation (EC) No 1907/2006 ( OJ L 353, 31.12.2008, p. 1 , ELI: http://data.europa.eu/eli/reg/2008/1272/oj ).

Other acts of the same type
Commission Implementing Regulation (EU) 2025/1171 of 16 June 2025 granting a Union authorisation for the biocidal product family PRODHYNET’s Lactic acid based products in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the CouncilCommission Implementing Regulation (EU) 2025/1177 of 16 June 2025 approving the active substance lysate of Willaertia magna as a low-risk active substance in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011Commission Implementing Regulation (EU) 2025/1220 of 16 June 2025 concerning the classification of certain goods in the Combined NomenclatureCommission Implementing Regulation (EU) 2025/1221 of 16 June 2025 concerning the classification of certain goods in the Combined NomenclatureCommission Delegated Regulation (EU) 2025/2169 of 16 June 2025 amending Regulation (EU) 2019/1241 of the European Parliament and of the Council as regards an increase of the minimum mesh size when fishing for squid in the North Sea and North Western WatersCommission Regulation (EU) 2025/1163 of 13 June 2025 amending Annexes II, III and V to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for chlorpropham, fuberidazole, ipconazole, methoxyfenozide, S-metolachlor and triflusulfuron in or on certain productsCommission Regulation (EU) 2025/1164 of 13 June 2025 amending Annexes II and III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for cyantraniliprole, cyflumetofen, deltamethrin, mefentrifluconazole, mepiquat and oxathiapiprolin in or on certain productsCommission Implementing Regulation (EU) 2025/1165 of 13 June 2025 laying down specific rules for the application of Regulation (EU) 2023/1231 of the European Parliament and of the Council as regards the information to be included in the pet travel document and declaration for non-commercial movements of certain pet animals entering into Northern Ireland from other parts of the United KingdomCommission Implementing Regulation (EU) 2025/1166 of 13 June 2025 fixing the adjustment rate for direct payments pursuant to Regulation (EU) 2021/2116 of the European Parliament and of the Council in respect of the calendar year 2025Commission Implementing Regulation (EU) 2025/1189 of 13 June 2025 imposing provisional anti dumping duties on imports of screws without heads originating in the People’s Republic of ChinaCommission Implementing Regulation (EU) 2025/1116 of 12 June 2025 granting a Union authorisation for the biocidal product family PAA family UCO Group in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the CouncilCommission Delegated Regulation (EU) 2025/1143 of 12 June 2025 supplementing Regulation (EU) No 600/2014 of the European Parliament and of the Council with regard to regulatory technical standards on the authorisation and organisational requirements for approved publication arrangements and approved reporting mechanisms, and on the authorisation requirements for consolidated tape providers, and repealing Commission Delegated Regulation (EU) 2017/571

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next